Mobile app support for home maintenance therapy in childhood leukemia
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests whether using a mobile app to track daily medication and weekly blood tests can help children with acute lymphoblastic leukemia (ALL) continue maintenance therapy safely at home, without needing to stay in the hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child was diagnosed with ALL before turning 16 years old
- Child has used a mobile app to log daily medicine and weekly blood test results for at least 3 months, with over 90% of records completed
- Child is no longer receiving chemotherapy in the hospital
- Parent or legal guardian agrees to participate and signs a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a mobile (phone) health program to help adolescents and young adults with leukemia take their oral chemotherapy medicine consistently. It may help if staying on daily pills is hard during the maintenance phase of treatment.
This study tests a support program that helps parents give their child's daily leukemia medicine (6-MP) on schedule and overcome any barriers. It aims to make it easier for families to stick with treatment.
This study tests a mobile health program to help teens and young adults with leukemia sit less during their maintenance therapy. The program uses a fitness tracker and group support to encourage more movement, which may improve health and well-being.
This trial tests a cell phone program to help teens manage their daily medications. It aims to make sticking to a medication routine easier for young people with long-term health conditions.
This study tests a smartphone or tablet app that helps childhood cancer survivors (or their caregivers) manage long-term follow-up care. If you attend the UCSF Survivorship Clinic, the app may make it easier to understand what care you need and stay on track.
This study checks whether a tablet-based tool (called PeNAT) can be used by children during the usual maintenance treatment phase for ALL (a type of leukemia). It may help families and clinicians better support care at home or during follow-up by testing how well the tool works in real patients.
Hear when a new Pediatric Acute Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.